AR082766A1 - Derivados de quinolizidina e indolizidina - Google Patents
Derivados de quinolizidina e indolizidinaInfo
- Publication number
- AR082766A1 AR082766A1 ARP110102139A ARP110102139A AR082766A1 AR 082766 A1 AR082766 A1 AR 082766A1 AR P110102139 A ARP110102139 A AR P110102139A AR P110102139 A ARP110102139 A AR P110102139A AR 082766 A1 AR082766 A1 AR 082766A1
- Authority
- AR
- Argentina
- Prior art keywords
- giyt
- compounds
- inhibitors
- lower alkyl
- glycine transporter
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La presente, se refiere a compuestos de la fórmula general (1) ó (2) en donde, X, es un enlace o un grupo -CH2; R1, R2 y R3 son, de una forma independiente, las unas con respecto a las otras, hidrógeno, alcoxi inferior, alquilo inferior sustituido por halógeno, ó S-alquilo inferior; o a sales de adición de ácidos, farmacéuticamente aceptables, a una mezcla racémica, o sus correspondientes enantiómeros y/o isómeros ópticos de éste. Se ha encontrado el hecho de que, los compuestos de las fórmulas generales (1) y (2), son buenos inhibidores del transportador de glicina 1 (GIyT-1), y que éstos tienen una buena selectividad a los inhibidores del transportador de glicina 2 (GIyT-2), apropiados en el tratamiento de los trastornos neurológicos y neuropsiquiátricos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10166776 | 2010-06-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR082766A1 true AR082766A1 (es) | 2013-01-09 |
Family
ID=44314179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP110102139A AR082766A1 (es) | 2010-06-22 | 2011-06-21 | Derivados de quinolizidina e indolizidina |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US8143273B2 (es) |
| EP (1) | EP2585460B1 (es) |
| JP (1) | JP5659299B2 (es) |
| KR (1) | KR101431949B1 (es) |
| CN (1) | CN102947301B (es) |
| AR (1) | AR082766A1 (es) |
| AU (1) | AU2011269147A1 (es) |
| BR (1) | BR112012030886A2 (es) |
| CA (1) | CA2797874C (es) |
| CL (1) | CL2012003553A1 (es) |
| CO (1) | CO6630104A2 (es) |
| CR (1) | CR20120601A (es) |
| EA (1) | EA201291281A1 (es) |
| ES (1) | ES2523572T3 (es) |
| HK (1) | HK1179609A1 (es) |
| IL (1) | IL222602A0 (es) |
| MA (1) | MA34250B1 (es) |
| MX (1) | MX2012013580A (es) |
| PE (1) | PE20130776A1 (es) |
| SG (1) | SG186327A1 (es) |
| TW (1) | TWI412526B (es) |
| WO (1) | WO2011161008A1 (es) |
| ZA (1) | ZA201209089B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014199960A1 (ja) * | 2013-06-10 | 2014-12-18 | 大正製薬株式会社 | グリシントランスポーター阻害物質 |
| KR102380870B1 (ko) | 2019-06-19 | 2022-03-31 | 한양대학교 에리카산학협력단 | 퀴놀리지딘 화합물 및 그 제조방법 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA795318B (en) * | 1978-10-13 | 1980-09-24 | Hoffmann La Roche | Phenyl quinolizidines |
| NZ191763A (en) | 1978-10-13 | 1984-05-31 | Hoffmann La Roche | 7-beta-phenyl-quinolidines, intermediates and pharmaceutical compositions |
| EP0067565A1 (en) * | 1981-06-16 | 1982-12-22 | Beecham Group Plc | Pharmaceutically active compounds |
| JP2004510712A (ja) * | 2000-09-22 | 2004-04-08 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | オクタヒドロ−インドリジンおよびキノリジンおよびヘキサヒドロ−ピロリジン |
| WO2003055856A2 (en) * | 2001-10-17 | 2003-07-10 | Bristol-Myers Squibb Company | BICYCLIC LACTAM DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE) |
| FR2906251B1 (fr) | 2006-09-22 | 2008-11-07 | Sanofi Aventis Sa | Derives de pyrrolizine, indolizine et quinolizine, leur preparation et leur application en therapeutique |
| US20110306597A1 (en) * | 2008-06-18 | 2011-12-15 | James Michael Crawforth | Nicotinamide Derivatives |
-
2011
- 2011-06-16 US US13/161,534 patent/US8143273B2/en not_active Expired - Fee Related
- 2011-06-17 WO PCT/EP2011/060077 patent/WO2011161008A1/en active Application Filing
- 2011-06-17 MX MX2012013580A patent/MX2012013580A/es active IP Right Grant
- 2011-06-17 EA EA201291281A patent/EA201291281A1/ru unknown
- 2011-06-17 ES ES11726146.1T patent/ES2523572T3/es active Active
- 2011-06-17 AU AU2011269147A patent/AU2011269147A1/en not_active Abandoned
- 2011-06-17 JP JP2013515818A patent/JP5659299B2/ja active Active
- 2011-06-17 KR KR1020127032605A patent/KR101431949B1/ko active IP Right Grant
- 2011-06-17 CA CA2797874A patent/CA2797874C/en not_active Expired - Fee Related
- 2011-06-17 BR BR112012030886A patent/BR112012030886A2/pt not_active IP Right Cessation
- 2011-06-17 EP EP11726146.1A patent/EP2585460B1/en active Active
- 2011-06-17 PE PE2012002454A patent/PE20130776A1/es not_active Application Discontinuation
- 2011-06-17 SG SG2012091682A patent/SG186327A1/en unknown
- 2011-06-17 MA MA35397A patent/MA34250B1/fr unknown
- 2011-06-17 CN CN201180030484.9A patent/CN102947301B/zh active Active
- 2011-06-20 TW TW100121497A patent/TWI412526B/zh not_active IP Right Cessation
- 2011-06-21 AR ARP110102139A patent/AR082766A1/es unknown
-
2012
- 2012-10-10 CO CO12178886A patent/CO6630104A2/es active IP Right Grant
- 2012-10-22 IL IL222602A patent/IL222602A0/en unknown
- 2012-11-28 CR CR20120601A patent/CR20120601A/es unknown
- 2012-11-30 ZA ZA2012/09089A patent/ZA201209089B/en unknown
- 2012-12-17 CL CL2012003553A patent/CL2012003553A1/es unknown
-
2013
- 2013-06-05 HK HK13106614.8A patent/HK1179609A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN102947301B (zh) | 2015-02-11 |
| SG186327A1 (en) | 2013-01-30 |
| EP2585460A1 (en) | 2013-05-01 |
| EP2585460B1 (en) | 2014-10-01 |
| MX2012013580A (es) | 2013-01-24 |
| CO6630104A2 (es) | 2013-03-01 |
| BR112012030886A2 (pt) | 2016-11-08 |
| WO2011161008A1 (en) | 2011-12-29 |
| CA2797874C (en) | 2018-04-24 |
| EA201291281A1 (ru) | 2013-06-28 |
| MA34250B1 (fr) | 2013-05-02 |
| AU2011269147A1 (en) | 2012-11-01 |
| US8143273B2 (en) | 2012-03-27 |
| CL2012003553A1 (es) | 2013-03-22 |
| TWI412526B (zh) | 2013-10-21 |
| US20110313165A1 (en) | 2011-12-22 |
| CR20120601A (es) | 2013-01-03 |
| IL222602A0 (en) | 2012-12-31 |
| JP2013529609A (ja) | 2013-07-22 |
| KR20130028756A (ko) | 2013-03-19 |
| CN102947301A (zh) | 2013-02-27 |
| PE20130776A1 (es) | 2013-07-03 |
| ES2523572T3 (es) | 2014-11-27 |
| CA2797874A1 (en) | 2011-12-29 |
| HK1179609A1 (en) | 2013-10-04 |
| KR101431949B1 (ko) | 2014-08-19 |
| ZA201209089B (en) | 2013-08-28 |
| JP5659299B2 (ja) | 2015-01-28 |
| TW201206928A (en) | 2012-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2012001911A1 (es) | Compuestos derivados de fumarato; composicion farmaceutica que los comprende; y su uso en el tratamiento de una enfermedad inflamatoria o neurodegenerativa. | |
| ECSP15012804A (es) | Alcoxipirazoles como activadores de guanilato ciclasa soluble | |
| AR075583A1 (es) | Derivados de isoxazol/o-piridina con eslabon etilo o etenilo | |
| PE20151860A1 (es) | Derivados de 6-(5-hidroxi-1h-pirazol-1-il)nicotinamida y su uso como inhidores de la phd | |
| UY33226A (es) | Compuestos de pirrolopirimidina deuterada como inhibidores de la cdk4/6 | |
| CO7131360A2 (es) | Novedosas n-piridinil amidas cíclicas sustituidas como inhibidores de quinasa | |
| CR20140133A (es) | Compuestos de piridazinona y sus usos como inhibidores de daao | |
| AR076008A1 (es) | Derivados de hidroximetil-isoxazol moduladores de receptores gaba a, composiciones farmaceuticas que los contienen, metodo para prepararlos y uso de los mismos para el tratamiento del alzheimer y otros trastornos cognitivos. | |
| UY33557A (es) | Inhibidores de oxadiazol de la produccion de leucotrieno | |
| AR085088A1 (es) | Inhibidores de histona desacetilasa y composiciones farmaceuticas que los contienen | |
| PE20142081A1 (es) | Inhibidores de quinurenina-3-monooxigenasa, composiciones farmaceuticas y metodo de uso de los mismos | |
| NI200900134A (es) | Derivados de imidazol como inhibidores de proteína de huso de cinesina (eg-5). | |
| ECSP088700A (es) | Acidos 4-fenil-tiazol-5-carboxilicos y amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1 | |
| AR087915A1 (es) | N-(3-(2-amino-6,6-difluor-4,4a,5,6,7,7a-hexahidro-ciclopenta-[e][1,3]oxazin-4-il)-fenil)-amidas como inhibidores de la bace1 | |
| CR20150419A (es) | Derivados sustituidos del ácido bisfenil butanóico fosfónico como inhibidores de la nep | |
| AR077534A1 (es) | Derivados de isoxazol, un proceso para su obtencion, composiciones farmaceuticas que los contienen y su uso en el tratamiento de enfermedades relacionadas con el receptor gaba aalfa5 | |
| AR092555A1 (es) | 2-oxo-2,3-dihidro-indoles y su utilizacion para el tratamiento de trastornos del snc | |
| UY35551A (es) | Derivados heteroarilos como inhibidores de aldosterona sintasa | |
| AR086036A1 (es) | DERIVADOS DE ETINILO COMO MODULADORES ALOSTERICOS POSITIVOS DE (mGluR5) | |
| ECSP099779A (es) | [4-(6-fluoro-7-metilamina-2,4-dioxo-1,4-dihidro-2h-quinazolina-3-ilo)-fenilo]-5-cloro tiofeno-2-ilo-sales de sulfonilurea, y las formas y métodos relacionados con el mismo | |
| AR097721A1 (es) | Derivados de etinilo | |
| CO6321280A2 (es) | Nueva clase espiro piperidinas para el tratamiento de enfermedades neurodegenerativas | |
| ECSP11011196A (es) | Derivados de piperidina | |
| ECSP13012548A (es) | Inhibidores de oxadiazol de la producción de leucotrienos. | |
| CR20130476A (es) | Derivados de pirazolidin-3-ona |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |